Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of Nasopharyngeal Carcinoma Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area

Publisher： Karger

E-ISSN： 2296-5262|37|3|88-95

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.3, 2014-02, pp. : 88-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China

By  

CANCER, Vol. 120, Iss. 9, 2014-05 ,pp. : 1353-1360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2720-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Progression of Sensorineural Hearing Loss and Tinnitus after Combined Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 743-751

Karger

Access to resources Recommend Favorite

A Novel Application of Plasma and Cerebrospinal Fluid Level of Epstein Barr Virus DNA in the Diagnosis of Leptomeningeal Metastasis from Nasopharyngeal Carcinoma

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 119-122

Karger

Access to resources Recommend Favorite

Genotypic Analysis of Epstein-Barr Virus Isolates Associated with Nasopharyngeal Carcinoma in Northern China

By  

Intervirology, Vol. 54, Iss. 3, 2010-10 ,pp. : 131-138

Karger

Access to resources Recommend Favorite